8-KThe WireRoutine
Reg FD Disclosure
Filed Jan 12, 2026 · 5mo ago · Accession 0001819790-26-000002
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Tarsus Pharmaceuticals, Inc.
- Ticker
- TARS
- CIK
- 1819790
- Form type
- 8-K
- Filing date
- Jan 12, 2026
- Report date
- Jan 12, 2026
- Document
- tars-20260112.htm
- Size
- 2.9 MB